JVMCX
Price
$27.95
Change
-$0.06 (-0.21%)
Updated
Aug 28 closing price
Net Assets
24.02B
LMCQX
Price
$32.86
Change
+$0.01 (+0.03%)
Updated
Aug 28 closing price
Net Assets
1.12B
Interact to see
Advertisement

JVMCX vs LMCQX

Header iconJVMCX vs LMCQX Comparison
Open Charts JVMCX vs LMCQXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$27.95
Change-$0.06 (-0.21%)
VolumeN/A
Net Assets24.02B
Lord Abbett Mid Cap Stock R2
Price$32.86
Change+$0.01 (+0.03%)
VolumeN/A
Net Assets1.12B
JVMCX vs LMCQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVMCX vs. LMCQX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and LMCQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24B vs. LMCQX (1.12B). LMCQX pays higher dividends than JVMCX: LMCQX (0.24) vs JVMCX (0.00). JVMCX was incepted earlier than LMCQX: JVMCX (14 years) vs LMCQX (17 years). JVMCX (1.86) is less costly to investors than LMCQX (1.38). LMCQX is a more actively managed with annual turnover of: 53.00 vs. JVMCX (49.00). LMCQX has a lower initial minimum investment than JVMCX: LMCQX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -0.88 vs. LMCQX (-7.79). JVMCX return over 5 years is better than : 45.76 vs. LMCQX (34.88).
JVMCXLMCQXJVMCX / LMCQX
Total Expense Ratio1.851.38134%
Annual Report Gross Expense Ratio1.861.38135%
Fund Existence14 years17 years-
Gain YTD10.711-0.605-1,770%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets24B1.12B2,149%
Annual Yield % from dividends0.000.24-
Returns for 1 year-0.88-7.7911%
Returns for 3 years17.0712.62135%
Returns for 5 years45.7634.88131%
Returns for 10 years44.4036.03123%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGENF2.700.29
+11.99%
NervGen Pharma Corp.
PRRFY13.03N/A
N/A
Premier Foods Plc.
ALEGF7.65N/A
N/A
ALLEGRO EU SA
RVXCF0.07N/A
N/A
Resverlogix Corp.
BKFAF7.01N/A
N/A
BROOKFIELD CORP.